doi: 10.1161/hy0202.104270
(Hypertension. 2002;39:197.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
Association Between Pulse Pressure and C-Reactive Protein Among Apparently Healthy US Adults
From the Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Ga.
Correspondence to Jerome L. Abramson, Department of Medicine, Division of Cardiology, Emory University School of Medicine, 1256 Briarcliff Rd, Suite 1 North, Atlanta, GA 30306. E-mail jabram3{at}emory.edu
Elevated pulse pressure has been associated with an increased risk of cardiovascular disease, which is increasingly being seen as an inflammatory disease. Thus, the mechanism underlying the link between elevated pulse pressure and cardiovascular disease risk may be inflammation. However, investigators have not examined the relationship between pulse pressure and C-reactive protein, an inflammation marker that has been closely linked to cardiovascular risk. We examined the cross-sectional relationship between pulse pressure and C-reactive protein among 9867 healthy persons 17 years of age or older who participated in the Third National Health and Nutrition Examination Survey. The association between pulse pressure and the odds of having an elevated C-reactive protein level (
0.66 mg/dL) was assessed by logistic regression. In a model that adjusted for systolic blood pressure, demographic factors, cholesterol, measures of obesity, smoking, alcohol consumption, physical activity, and antihypertensive medication use, a 10 mm Hg increase in pulse pressure was associated with a 15% increase in the odds of having an elevated C-reactive protein level (odds ratio, 1.15; 95% confidence interval, 1.01 to 1.31; P=0.04). When the same model was re-run adjusting for diastolic blood pressure instead of systolic blood pressure, a 10 mm Hg rise in pulse pressure was associated with a significant 12% increase in the odds of having an elevated C-reactive protein level. Systolic and diastolic blood pressure were unrelated to C-reactive protein once pulse pressure had been accounted for. Our results suggest that increases in pulse pressure are associated with elevated C-reactive protein levels among apparently healthy US adults, independent of systolic and diastolic blood pressure.
Key Words: blood pressure • hypertension, essential • epidemiology • cross-sectional studies • risk factors
This article has been cited by other articles:
 |
|
 |
|
  P. Lacolley, M. E. Safar, V. Regnault, and E. D. Frohlich Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1567 - H1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V P van Halm, M J L Peters, A E Voskuyl, M Boers, W F Lems, M Visser, C D A Stehouwer, A M W Spijkerman, J M Dekker, G Nijpels, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation Ann Rheum Dis, September 1, 2009; 68(9): 1395 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Huang, C. Luo, X. Gu, Z. Wu, Z. Wang, Z. Du, C. Hu, and L. Tang Mechanical Strain Induces Expression of C-Reactive Protein in Human Blood Vessels J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 206 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lieb, M. G. Larson, E. J. Benjamin, X. Yin, G. H. Tofler, J. Selhub, P. F. Jacques, T. J. Wang, J. A. Vita, D. Levy, et al. Multimarker Approach to Evaluate Correlates of Vascular Stiffness: The Framingham Heart Study Circulation, January 6, 2009; 119(1): 37 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Lande, T. A. Pearson, R. P. Vermilion, P. Auinger, and I. D. Fernandez Elevated Blood Pressure, Race/Ethnicity, and C-Reactive Protein Levels in Children and Adolescents Pediatrics, December 1, 2008; 122(6): 1252 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schnabel, M. G. Larson, J. Dupuis, K. L. Lunetta, I. Lipinska, J. B. Meigs, X. Yin, J. Rong, J. A. Vita, C. Newton-Cheh, et al. Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection Hypertension, June 1, 2008; 51(6): 1651 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. N. Das Risk of type 2 diabetes mellitus in those with hypertension Eur. Heart J., April 1, 2008; 29(7): 952 - 953. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Safar Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension Hypertension, July 1, 2007; 50(1): 167 - 171. [Full Text] [PDF]
|
|
|
|
 |
|
 Yasmin, C. M. McEniery, K. M. O'Shaughnessy, P. Harnett, A. Arshad, S. Wallace, K. Maki-Petaja, B. McDonnell, M. J. Ashby, J. Brown, et al. Variation in the Human Matrix Metalloproteinase-9 Gene Is Associated With Arterial Stiffness in Healthy Individuals Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Gonzalez-Clemente, G Gimenez-Perez, C Richart, M Broch, A Caixas, A Megia, O Gimenez-Palop, I Simon, D Mauricio, and J Vendrell The tumour necrosis factor (TNF)-{alpha} system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus Eur. J. Endocrinol., November 1, 2005; 153(5): 687 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Roman, R. B. Devereux, J. E. Schwartz, M. D. Lockshin, S. A. Paget, A. Davis, M. K. Crow, L. Sammaritano, D. M. Levine, B.-A. Shankar, et al. Arterial Stiffness in Chronic Inflammatory Diseases Hypertension, July 1, 2005; 46(1): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Amar, J.-B. Ruidavets, J.-C. Peyrieux, J.-M. Mallion, J. Ferrieres, M. E. Safar, and B. Chamontin C-Reactive Protein Elevation Predicts Pulse Pressure Reduction in Hypertensive Subjects Hypertension, July 1, 2005; 46(1): 151 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y.-M. Wang, M. Wang, J. Woo, C. W.-K. Lam, S.-F. Lui, P. K.-T. Li, and J. E. Sanderson Inflammation, Residual Kidney Function, and Cardiac Hypertrophy Are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2186 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Yasmin, C. M. McEniery, S. Wallace, I. S. Mackenzie, J. R. Cockcroft, and I. B. Wilkinson C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 969 - 974. [Abstract] [Full Text]
|
|
|
|
|
|
G. J. Blake, N. Rifai, J. E. Buring, and P. M Ridker Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events Circulation, December 16, 2003; 108(24): 2993 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Napoli and F. Papa Association Between Blood Pressure and C-Reactive Protein Levels in Acute Ischemic Stroke Hypertension, December 1, 2003; 42(6): 1117 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Napoli Editorial Comment--C-Reactive Protein and Vascular Risk in Stroke Patients: Potential Use for the Future Stroke, October 1, 2003; 34(10): 2468 - 2470. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Myers, K. J. Harmon, V. Lindner, and L. Liaw Alterations of Arterial Physiology in Osteopontin-Null Mice Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aviv Chronology Versus Biology: Telomeres, Essential Hypertension, and Vascular Aging Hypertension, September 1, 2002; 40(3): 229 - 232. [Abstract] [Full Text] [PDF]
|
|